Investors may find better financial performance in Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc [SLNO] stock is trading at $87.64, up 2.48%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SLNO shares have gain 9.11% over the last week, with a monthly amount glided 12.14%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Soleno Therapeutics Inc [NASDAQ: SLNO] stock has seen the most recent analyst activity on June 23, 2025, when TD Cowen initiated its Buy rating and assigned the stock a price target of $110. On December 02, 2024, Stifel reiterated its Buy rating but maintained its price target of $74 on the stock. Robert W. Baird reiterated its Outperform rating but stick to its price target of $72 on December 02, 2024. H.C. Wainwright initiated its recommendation with a Buy and recommended $70 as its price target on September 03, 2024. Robert W. Baird started tracking with a Outperform rating for this stock on May 10, 2024, and assigned it a price target of $72. In a note dated February 05, 2024, Piper Sandler initiated an Overweight rating and provided a target price of $93 on this stock.

Soleno Therapeutics Inc [SLNO] stock has fluctuated between $41.50 and $90.32 over the past year. Currently, Wall Street analysts expect the stock to reach $102.33 within the next 12 months. Soleno Therapeutics Inc [NASDAQ: SLNO] shares were valued at $87.64 at the most recent close of the market. An investor can expect a potential return of 16.76% based on the average SLNO price forecast.

Analyzing the SLNO fundamentals

To continue investigating profitability, this company’s Return on Assets is posted at -0.62, Equity is -0.78 and Total Capital is -0.54. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.

Ratios To Look Out For

For context, Soleno Therapeutics Inc’s Current Ratio is 19.64. In addition, the Quick Ratio stands at 19.64 and the Cash Ratio stands at 5.17.

Transactions by insiders

Recent insider trading involved Hirano Patricia C, that happened on Jul 01 ’25 when 3830.0 shares were sold. Officer, PATRICIA HIRANO completed a deal on Jul 01 ’25 to buy 3830.0 shares. Meanwhile, Hirano Patricia C sold 266.0 shares on Jun 24 ’25.

Related Posts

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.